# Research Strategy: Gut Microbiome and Cognitive Flexibility

## 1. Introduction

This document outlines the research strategy for investigating the relationship between gut microbiome composition and cognitive flexibility. The strategy is divided into two distinct phases: an **Empirical Associational Phase** and a **Theoretical Mechanistic Phase**.

## 2. Phase 1: Empirical Associational Analysis (User Stories 1-3)

### 2.1 Objective
To identify statistical associations between specific microbial taxa and cognitive flexibility scores using large-scale public datasets.

### 2.2 Data Sources
* **Microbiome**: American Gut Project (AGP) via Qiita.
* **Cognitive**: UK Biobank (Field 20002) and NHANES Cognitive Battery.

### 2.3 Methodology
1. **Ingestion**: Download raw data, apply FR-001 filters (read depth, abundance).
2. **Preprocessing**: Impute missing values (MICE), normalize, and compute z-scores.
3. **Linkage Check**: Attempt to merge datasets on participant IDs.
 * **Success**: Proceed to correlation and regression.
 * **Failure**: Trigger **FR-008 Meta-Analysis Fallback** using synthetic literature statistics to ensure a measurable outcome is produced.
4. **Analysis**:
 * Spearman correlations with Benjamini-Hochberg FDR correction.
 * Regularized regression (Elastic Net) with CLR-transformed taxa.
5. **Sensitivity**: Stratify by age and compare normalization methods (DESeq2 vs. Rarefaction).

### 2.4 Constraints
* **Associational Only**: All results from this phase must be explicitly labeled as "associational." No causal inference is permitted.
* **Data Limitations**: Public datasets do not contain molecular markers (e.g., SCFA levels, histone acetylation). Therefore, this phase *cannot* validate mechanistic pathways.

## 3. Phase 2: Theoretical Mechanistic Synthesis (User Story 4)

### 3.1 Objective
To address the "cellular alphabet" gap by synthesizing existing literature into a testable hypothesis for future experimental validation.

### 3.2 Methodology
1. **Literature Synthesis**: Extract molecular entities (SCFA, BDNF, CREB, HDAC) from literature metadata.
2. **Hypothesis Generation**: Construct a graph linking Microbes -> Metabolites -> Neural Markers.
3. **Future Design**: Propose a specific experimental protocol (e.g., Gnotobiotic mice + Hippocampal Transcriptomics) to measure the proposed pathway.

### 3.3 Key Distinction
* **US1-US3 (Correlational)**: "We observed a statistical link between Taxon X and Cognitive Score Y."
* **US4 (Mechanistic)**: "Based on literature, Taxon X produces Metabolite Z, which inhibits HDAC, potentially upregulating BDNF. *However, this current study cannot measure Z or HDAC.* Future experiments must be designed to test this specific pathway."

## 4. Conclusion

This dual-phase strategy ensures scientific rigor by:
1. Providing measurable, real-data associations (or a meta-analytic fallback) in the absence of direct mechanistic data.
2. Explicitly acknowledging the limitations of the correlational approach.
3. Proposing a concrete, literature-grounded mechanism for future causal testing, satisfying the requirement for a "cellular alphabet" without overclaiming the current results.

**Explicit Statement**: "The current correlational analysis identifies associations; the proposed mechanistic pathway provides the biological plausibility for future causal testing."
